10/06/2025 04:01
Heidi Secures $65 Million USD in Series B Funding to Accelerate Building an AI Care Partner for Every Clinician

Heidi, the fast-growing healthcare AI company, today announced the closing of a $65 million Series B funding round, led by Point72 Private Investments with participation from continuing investors Blackbird, Headline, and Latitude, the growth fund of Phoenix Court. This round values Heidi at $465 million and brings total funding to nearly $100 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251005012225/en/Pictured (L-R): Hei...

10/06/2025 07:08
G2 Risk Solutions Finalizes EverC Transaction

G2 Risk Solutions (G2RS) today announced the completion of its transaction with EverC, expanding G2RS’ global reach and adding proven AI-powered risk solutions to its product suite. Now with the acquired capabilities of EverC, G2RS delivers a comprehensive suite of AI- and analyst-driven risk solutions. Products are built to help global banks, merchant acquirers and online marketplaces strengthen defenses against fraud, scams and illegal or unsafe transactions. This includes the recently laun...

10/06/2025 07:00
HumanX Takes AI's Biggest Stage to Europe with Amsterdam Expansion

HumanX, the world’s leading AI event, is officially coming to Europe. Built by the team behind Money20/20, Shoptalk, and HLTH, the organization announced today the launch of HumanX EMEA, a new global gathering taking place September 22-24, 2026, at The RAI in Amsterdam. Already established as the premier ecosystem enabling enterprise AI strategy, implementation, and cross-sector collaboration in the United States, HumanX now brings its proven platform to Europe at a time of historic momentum ...

10/06/2025 07:38
Omdia: Hyperscaler Cloud Marketplace Sales to Hit $163 Billion by 2030

New research from Omdia has revealed that enterprise software sales through hyperscaler cloud marketplaces - led by AWS, Microsoft, and Google Cloud - are projected to surge from $30 billion in 2024 to $163 billion by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251006925215/en/Share of channel spend via hyperscaler cloud marketplaces This growth reflects increasing enterprise adoption of marketplace procurement and a sharp ...

10/06/2025 08:05
Mercans Launches Groundbreaking AI Suite, Redefining Payroll as an Intelligent, Always-On Business Function

Mercans, a global leader in payroll technology and managed payroll services, today unveiled a sweeping suite of AI-powered innovations that mark a historic shift in the payroll industry. With this launch, Mercans positions itself not as a company with AI features, but as an AI-first organization, embedding intelligence into the very core of payroll, compliance, and client experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025...

10/06/2025 09:00
Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions

Celltrion, Inc. today showcased real-world evidence supporting the use of subcutaneous (SC) infliximab, confirming the efficacy and safety of switching to SC infliximab 120mg every two weeks in patients with inflammatory bowel disease (IBD). The real-world evidence was presented at the Meet the Expert (MTE) Sessions at UEG 2025, and included presentations from Professor Nicolas Mathieu, Medical Director of MICI Institut Privé, Cliniques des Cèdres and Associate Professor of Gastroenterology, ...

10/06/2025 09:43
Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study

Torqur AG, subsidiary of Swiss Rockets incubator and a clinical-stage company advancing targeted therapies in oncodermatology and oncology, announced the results of the full Phase 2 proof-of-concept study results of topical bimiralisib gel (2%) for the treatment of actinic keratosis (AK) at the European Academy of Dermatology and Venereology (EADV) Congress 2025 in Paris, the largest dermatology conference in Europe. The randomized, multi-center study evaluated topical bimiralisib gel as a fi...

10/06/2025 09:59
INVESTMENT FORUM - Senegal Is Betting on Forum Invest in Senegal 2025 (Fii 2025) to Accelerate the Inflow of Foreign Capital

As the landscape of foreign direct investment (FDI) flows into Africa is being reshaped, Senegal aims to capture a growing share of this capital through the Forum Invest in Senegal 2025 (Fii Senegal 2025) (http://apo-opa.co/3KzxBkp), which opens on Tuesday in Diamniadio. “Senegal is positioning itself as a crossroads between Africa and the rest of the world, a gateway for attracting capital, technology, and expertise,” explains Bakary Séga Bathily, Director General of APIX, the agency respons...

10/06/2025 11:05
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced new innovations and products that will be featured at The American Society for Histocompatibility and Immunogenetics (ASHI) 2025 Annual Meeting, held October 6th to 10th in Orlando, Florida. The company also announced that its...

10/06/2025 11:45
Butterfly Network Launches First-to-Market Artificial Intelligence Gestational Age Tool in Sub-Saharan Africa to Improve Maternal Health

Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the launch of a first-of-its-kind Gestational Age artificial intelligence (AI) tool in Malawi and Uganda. The tool is Butterfly’s latest innovation to improve maternal and fetal health through AI-aided point-of-care ultrasound (POCUS), and comes as the Company announces a milestone year for its obstetrical POCU...